Member Info for Arbitrage

https://www.investegate.co.uk/reneuron-group-plc--rene-/rns/phase-ii-stroke-data-presented-at-aha-conference/201801260700049885C/

are clearly evident and at play here, just as they have been since the date of the extremely positive, encouraging and greatly anticipated below rns: https://www.investegate.co.uk/falcon-oil---38--gas-ltd---fog-/gnw/falcon-oil---gas-ltd---draft-final-report-from----/20171212070011H5439/ "Whatever your dream, whatever your goal, keep your eye on the doughnut and not on the hole!" which, in the case of FOG, translates to 'hold for the prize' and in so doing, do not be influenced or, in any way distracted by the devious and deplorable tactics of the 'bastardos' that are the devious and manipulative pond-life a.k.a. MM's.

https://www.investegate.co.uk/amryt-pharma-plc--amyt-/rns/new-distribution-agreement-signed/201801100700024150B/

"Lojuxta is a treatment for Homozygous Familial Hypercholesterolemia ("HoFH"), a rare, life-limiting disease, which impairs the body's ability to remove LDL cholesterol ("bad" cholesterol) from the blood. Starting before birth, the disease progresses rapidly, and typically results in extremely high blood LDL cholesterol levels, which leads to aggressive and premature narrowing and blocking of blood vessels." In light of the above, is it not logical to conclude that given it's proven scientific pedigree and ability to significantly reduce LDL cholesterol, that the BOD of Amryt could well posses the ability to 'tweak' the Lojuxta molecule in order to treat a significant percentage of the global population diagnosed with both Obesity and Diabetes, whose associated side effects include LDL Cholesterol and in so doing, successfully target a substantial share of the $163 billion market to 2022 (as outlined before courtesy of Business Wire). https://www.businesswire.com/news/home/20160831005487/en/Global-163-Billion-Diabetes-Obesity-Drugs-Market

surely common sense screams out at the BOD that the smart play re the commercial development of the Paradox Basin is to open up a 'data room' with immediate effect and having so done, then to invite all would-be farmees to express their interest by a predetermined date. In so doing, both the associated costs, along with the accompanying risks are substantially diminished and are not yet again being fully borne by 'us' the shareholders in ROSE and if, the Paradox Basin is indeed determined to be as prolific as has been alluded to via the successful extrapolation of our seismic data, then I for one would be quite happy to retain anywhere between a 20% - 40% working interest in respect of the entire project, in return for an upfront cost-to-date covering cash payment, along with a 'full-carry' in respect of our entire acreage position. In essence, I would suggest that the 'smart play' from this point forward by the BOD of ROSE on behalf of their shareholders would be to replicate the approach adopted by the BOD of Falcon Oil & Gas (FOG), as outlined below: https://www.investegate.co.uk/falcon-oil---38--gas-ltd--fog-/mkw/falcon-oil--amp--gas-ltd---transformational-far---/20140502070008M2473/

https://www.investegate.co.uk/amryt-pharma-plc--amyt-/rns/distribution-agreement-signed-covering-switzerland/201801080700031618B/

in PMG i.e. down .25p to close 2017 at 36.25p which, I believe to be best encapsulated in the word 'pathetic'. It's high time that this 'band of brothers' from the Dana days (a.k.a. the PMG BOD), started to create some true and meaningful shareholder value here, as opposed to quietly relinquishing licences and recreating a 'ground-hog day scenario' day after day, week after week and month after month. In truth, that which went before is meaningless, as in this industry, you're only as good as the results you're producing in respect of the current company you're running! Now, get your finger out TC and start delivering the goods with immediate effect, on behalf of your loyal and trusting shareholders!

https://www.investegate.co.uk/salt-lake-potash-ltd--so4-/rns/results-of-lake-way-reconnaissance-work/201712111100019618Y/

https://www.investegate.co.uk/salt-lake-potash-ltd--so4-/rns/september-2017-quarterly-report/201710310700029937U/

https://www.investegate.co.uk/reneuron-group-plc--rene-/rns/positive-stroke-clinical-data---regulatory-update/201710310700040636V/

I find it absolutely unbelievable that on a day when Brent Crude breaks through the $60 per barrel, PMG falls another circa 3%. High time that TC & his fellow BOD members suspended share trading in this company and called for a 'stewards inquiry' or, preferably an FCA/AIM Regulation investigation into just what is happening in respect of the manipulation of theirs and 'our' company and by whom!

High time the Management of this company got their act together (quick style!) and stopped floundering around, as their abysmal stewardship of this company to date, along with the ongoing squandered potential on every front is fast becoming 'farcical' and I can only hazard a guess as to what Neil Woodford must be thinking about the plummeting value of his 'Funds' investment in this company to date.

https://www.investegate.co.uk/rose-petroleum-plc--rose-/rns/holding-s--in-company/201710251708076352U/

https://www.investegate.co.uk/salt-lake-potash-ltd--so4-/rns/low-cost--on-lake-evaporation-pond-model-confirmed/201710160751326586T/

https://www.investegate.co.uk/rose-petroleum-plc--rose-/rns/holding-s--in-company/201710121817584975T/

https://www.investegate.co.uk/amryt-pharma-plc--amyt-/rns/result-of-general-meeting---completion-of-placing/201710091213200801T/ Imo, the content of the above rns can be taken to represent a ringing endorsement by the Directors of AMYT as to both their desire and commitment to deliver on the company's stated corporate aims and strategy and in addition to confirming their confidence in the progression of the various ongoing advanced clinical trials, today's rns also conveys an overall message of positivity to shareholders and 'The Market'.

http://www.proactiveinvestors.co.uk/register/event_details/110 Following on from Rory Nealon's recent attendance and presentation at the Rodman and Renshaw NYC Annual Healthcare Conference, tomorrows event affords representatives of AMYT a further positive opportunity to promote the company's extremely positive achievements to date, together with the opportunity to outline the company's future key milestone targets.

Court proceedings 'kick-off' next Wednesday for the company's 'illustrious' ex Former chief executive Osman Shahenshah and chief operating officer Shahid Ullah, who will appear at Westminster Magistrates Court on Wednesday. It follows a two-year investigation by the Serious Fraud Office (SFO). Afren, once valued on the FTSE 250 index at �2.6bn, collapsed in 2015 after the oil price slump and the failure of an Iraqi Kurdistan project. The two men face four charges related to payments they received through secret companies that were linked to �298m ($400m) worth of Nigerian business deals. It is being claimed that the alleged fraud led to the collapse of Afren which is now in administration. Mr Shahenshah - who was sacked along with three other directors over gross misconduct in 2014 - and Mr Ullah will be charged with two counts of fraud by abuse of position, and two separate counts of money laundering. The SFO said that Afren's administrators AlixPartners are seeking damages worth more than �500m from Mr Shahenshah, Mr Ullah and one of their Nigerian associates, in related civil claims.

given that you publicly stated earlier this week of your intention to immediately sell what little holding you have here and to move on, then i'm somewhat surprised to find you still posting your diatribe here and I for one won't miss your constant whining and negativity as to what the BOD have and continue to achieve both on behalf of ourselves i.e. AMYT's shareholders, along with those unfortunate individuals in society who will hopefully, at some future point benefit considerably from that which the company is striving to achieve. Indeed, unless i'm mistaken or your have multiple posting alias, then my recent exchanges were actually with jmr1980 so, unless you have something of a constructive nature to add to that particular posting exchange, then I suggest you kindly 'wind your neck in'. By way of contradiction to your accusation of me 'pumping this share for over a year', you are yet again sadly mistaken, as the sharing of research info along with the provision of a balanced opinion does not, I assure you, by any stretch of the imagination, deem me meritorious of the the term 'PUMPER' (not even if your shouting it at me). Anyhow, given that, by your own admission you'll soon be gone from this BB, then I'll take what could well prove to be the last opportunity to wish you every successl with any other holdings which you may have.

http://www.proactiveinvestors.co.uk/companies/stocktube/8120/amryt-pharma-to-raise-15mln-for-drug-to-treat-rare-skin-condition-8120.html